Daxor Market Cap 2010-2011 | DXR

Daxor market cap history and chart from 2010 to 2011. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Daxor market cap as of April 25, 2024 is $0.05B.
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.047B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.509B 9.99
Quest Diagnostics (DGX) United States $15.276B 15.79
DaVita (DVA) United States $11.641B 15.84
Chemed (CHE) United States $9.342B 29.00
Encompass Health (EHC) United States $8.292B 21.34
Elanco Animal Health (ELAN) United States $6.576B 14.95
Option Care Health (OPCH) United States $5.202B 19.69
RadNet (RDNT) United States $3.333B 97.34
Amedisys (AMED) United States $2.974B 21.08
LifeStance Health (LFST) United States $2.358B 0.00
Astrana Health (ASTH) United States $2.051B 25.88
U.S Physical Therapy (USPH) United States $1.562B 40.49
Addus HomeCare (ADUS) United States $1.550B 23.76
Pennant (PNTG) United States $0.622B 36.33
Aveanna Healthcare Holdings (AVAH) United States $0.444B 0.00
Atai Life Sciences (ATAI) Germany $0.313B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00